Array-based multiplex analysis of DNA methylation in breast cancer tissues

Journal of Molecular Diagnostics

Volumn 10, Issue 1, 2008, Pages 93-101

  Melnikov, Anatoliy A ^a   Scholtens, Denise M ^a   Wiley, Elizabeth L ^a,b   Khan, Seema A ^a   Levenson, Victor V ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; FORMALDEHYDE; GENOMIC DNA; PARAFFIN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BAYES THEOREM; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; BREAST HYPERPLASIA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INVASION; CANCER TISSUE; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION; VALIDATION PROCESS;

EID: 38749121383     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.070077     Document Type: Article

References (39)

1. Knutson D, Steiner E: Screening for breast cancer: current recommendations and future directions. Am Fam Physician 2007, 75:1660-1666
2. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004, 233:830-849
3. Baylin SB, Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006, 6:107-116
4. Jones PA: Overview of cancer epigenetics. Semin Hematol 2005, 42:S3-S8
5. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153
6. Taback B, Hoon DS: Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann NY Acad Sci 2004, 1022:1-8
7. Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, Klocker H, Goebel G, Widschwendter M: Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 2005, 65:1141-1145
8. Melnikov AA, Gartenhaus RB, Levenson AS, Motchoulskaia NA, Levenson Chernokhvostov VV: MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res 2005, 33:e93
9. Bhandare DJ, Khan SA, Motchoulskaia NA, Melnikov AA, Levenson Chernokhvostov VV: Isolation of highly purified DNA from low-abundance archived and stained cytological specimens. Clin Chim Acta 2006, 367:211-213
10. Jensen RA, Dupont WD, Page DL: Diagnostic criteria and cancer risk of proliferative breast lesions. J Cell Biochem Suppl 1993, 17G:59-64
11. MacGrogan G, Tavassoli FA: Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 2003, 443:609-617
12. Barnes WM: PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc Natl Acad Sci USA: 1994, 91:2216-2220
13. Leonard GD, Low JA, Berman AW, Swain SM: CA 125 elevation in breast cancer: a case report and review of the literature. Breast J 2004, 10:146-149
14. Rajan PB, Scott DJ, Perry RH, Griffith CD: p53 protein expression in ductal carcinoma in situ (DCIS) of the breast. Breast Cancer Res Treat 1997, 42:283-290
15. Tan P, Ho G, Ji C, Ng E, Gao F, Bay B: Immunohistochemical expression of p53 protein in invasive breast carcinoma: clinicopathologic correlations. Oncol Rep 1999, 6:1159-1163
16. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15
17. Scholtens D, von Heydebreck A: Analysis of differential gene expression. In Studies in Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Edited by HW Gentleman, R Irizarry, S Dudoit. Berlin, Springer, 2005, pp 229-248
18. Model F, Adorján P, Olek A, Piepenbrook C: Feature selection for DNA methylation based cancer classification. Bioinformatics 2001, 17 Suppl 1:S157-S164
19. Domingos P, Pazzani MJ: On the optimality of the simple Bayesian classifier under zero-one loss. Machine Learning 1997, 29:103-130
20. Worm J, Kirkin AF, Dzhandzhugazyan KN, Guldberg P: Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate- resistant human breast cancer cells. J Biol Chem 2001, 276:39990-40000
21. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80
22. Herman JG. Epigenetics in lung cancer: focus on progression and early lesions. Chest 2004, 125:119S-122S.
23. Brena RM, Huang TH, Plass C: Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med 2006, 84:365-377
24. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-30
25. Grunau C, Clark SJ, Rosenthal A: Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29:E65-5
26. Munson K, Clark J, Lamparska-Kupsik K, Smith SS: Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR. Nucleic Acids Res 2007, 35:2893-2903
27. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ: Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997, 25:4422-4426
28. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001, 20:3348-3353
29. Iyer NG, Chin SF, Ozdag H, Daigo Y, Hu DE, Cariati M, Brindle K, Aparicio S, Caldas C: p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad Sci USA 2004, 101:7386-7391
30. Beitzinger M, Oswald C, Beinoraviciute-Kellner R, Stiewe T: Regulation of telomerase activity by the p53 family member p73. Oncogene 2006, 25:813-826
31. Albo D, Shinohara T, Tuszynski GP: Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J Surg Res 2002, 108:51-60
32. Hashimoto T, Kusakabe T, Sugino T, Fukuda T, Watanabe K, Sato Y, Nashimoto A, Honma K, Kimura H, Fujii H, Suzuki T: Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis. Pathobiology 2004, 71:267-273
33. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R: Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun 2004, 321:455-461
34. Widschwendter M, Jones PA: DNA methylation and breast carcinogenesis. Oncogene 2002, 21:5462-5482
35. Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 2005, 11:2156-2162
36. Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM: Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 2005, 11:166-172
37. Fiegl H, Millinger S, Goebel G, Müller-Holzner E, Marth C, Laird PW, Widschwendter M: Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 2006, 66:29-33
38. Li S, Rong M, Iacopetta B: DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 2006, 237:272-280
39. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S: Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 2006, 12:3306-3310